TrialAlimentary pharmacology & therapeutics2025

Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha-2-Delta Ligand PD-217,014 in Patients With Irritable Bowel Syndrome.

Lesley A Houghton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.